The link between public and private insurance and HIV-related mortality

Journal of Health Economics

Volumn 22, Issue 6, 2003, Pages 1105-1122

  Bhattacharya, Jayanta ^a   Goldman, Dana ^b   Sood, Neeraj ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RAND CORPORATION   (United States)

Author keywords

Health outcomes; HIV; Insurance; Medicaid; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT;

HUMAN IMMUNODEFICIENCY VIRUS;

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL CARE; PRESCRIPTION; PRIVATE HEALTH INSURANCE;

EID: 0242266469     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2003.07.001     Document Type: Article

References (26)

1. Andersen R., Bozzette S., Shapiro M., St. Clair P., Goldman D., Wenger N. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV in the US. Health Services Research. 35(3):1999;389-416.
2. Bound J., Jaeger D., Baker R. Problems with instrumental variables estimation when the correlation between the instruments and the endogenous explanatory variable is weak. Journal of the American Statistical Association. 90(430):1995;443-450.
3. Bundorf K. Employee demand for health insurance and employer health plan choices. Journal of Health Economics. 21(1):2002;65-88.
4. Cantor C., Long S., Marquis S. Private employment-based health insurance in ten states. Health Affairs. 14(2):1995;199-211.
5. Center for Disease Control, 1998. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance - United States, January 1994-June 1997. Morbidity and Mortality Weekly Report 47 (15), 309-314.
6. Cutler D. The incidence of adverse medical outcomes under prospective payment. Econometrica. 63(1):1995;29-50.
7. Cutler D., Gruber J. Does public insurance crowd out private insurance? Quarterly Journal of Economics. 111(2):1996;391-430.
8. Duan, N., McCaffrey, D.F., Frankel, M.R., St. Clair, P.A., Beckman, R., Keesey, J.W., Chien, C., Goldman, D.P., Smith, S., Morton, S.C., 1999. Hcsus baseline methods technical report: weighting, imputation and variance estimation. RAND Report MR-1060-AHCPR, RAND, Santa Monica, CA.
9. Employee Benefit Research Institute, 2001. Sources of health insurance and characteristics of the uninsured: Analysis of the march 2001 current population survey. EBRI Issue Brief #240.
10. Fauci, A., Braunwald, E., Isselbacher, K., Martin, J. (Eds.), 1998. Harrison's Principles of Internal Medicine, 11th ed. Mc-Graw Hill, New York.
11. Fleishman J., Hsia D., Hellinger F. Correlates of medical service utilization among people with HIV infection. Health Services Research. 29(5):1994;527-538.
12. Goldman D. Managed care as a public cost containment mechanism. RAND Journal of Economics. 26(2):1995;277-295.
13. Goldman D., Bhattacharya J., McCaffrey D., Duan N., Leibowitz A., Joyce G., Morton S. The effect of insurance on mortality in an HIV+ population in care. Journal of the American Statistical Association. 96(405):2001;883-894.
14. Goldman D., Smith J. Can patient self-management help explain the SES health gradient? Proceedings of the National Academy of Sciences. 99(16):2002;10929-10934.
15. Heckman J. Micro data, heterogeneity, and the evaluation of public policy: nobel lecture. Journal of Political Economy. 109:2001;673-748.
16. Horner R., Bennett C., Achenbach C., Rodriguez D., Adams J., Gilmann S., Cohn S., Dickinson G., DeHovitz J., Weinstein R. Predictors of resource utilization for hospitalized patients with Pneumocystis carinii pneumonia (pcp): a summary of effects from the multi-city study of quality of pcp care. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12:1996;379-385.
17. Institute of Medicine, 2002. Care Without Coverage: Too Little, Too Late. Institute of Medicine.
18. Joyce G., Goldman D., Leibowitz A., Duan N., Carlisle D., Shapiro M., Bozzette S. Variation in inpatient resource use in the treatment of HIV: do the privately insured receive more care? Medical Care. 37(3):1998;220-227.
19. Lancaster T., Intrator O. Panel data with survival: hospitalization of HIV-positive patients. Journal of the American Statistical Association. 93(441):1998;46-53.
20. Levy, H., Meltzer, D., 2001. What do we really know about whether health insurance affects health? Working Paper #274, Joint Center for Poverty Research.
21. Mroz T. Discrete factor approximations in simultaneous equation models: Estimating the impact of a dummy endogenous variable on continuous outcomes. Journal of Econometrics. 92(2):1999;233-274.
22. Nelson C.R., Startz R. Some further results on the exact small sample properties of the instrumental variable estimator. Econometrica. 58(4):1990;967-976.
23. Nyman J. The value of health insurance: the access motive. Journal of Health Economics. 18(2):1999;141-152.
24. Palella F., Delaney K., Moorman A., Loveless M., Fuhrer J., Satten G., Aschman D., Holmberg S. The HIV outpatient study investigators: declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 338(13):1998;853-860.
25. Shapiro M.F., Morton S.C., McCaffrey D.F., Andersen R.M., Berk M.L., Bing E.G., Cleary P.D., Cunningham W.E., Fleishman J.A., Kanouse D.E., Senterfitt J.W., Bozzette S.A. Variations in the care of HIV-infected adults in the United States: results from the HIV cost and services utilization study. Journal of the American Medical Association. 281:1999;2305-2315.
26. Staiger D., Stock J.H. Instrumental variables regression with weak instruments. Econometrica. 65(3):1997;557-586.